2025 ICD-10 PCS INDEX TERMS STARTING WITH 3

  • Introduction Peripheral Artery to Clofarabine with Antineoplastic, Open Approach - 3E0500P
  • Introduction Peripheral Artery to Recombinant Human-activated Protein C with Thrombolytic, Open Approach - 3E05016
  • Introduction Peripheral Artery to Other Thrombolytic with Thrombolytic, Open Approach - 3E05017
  • Introduction Peripheral Artery to Oxazolidinones with Anti-infective, Open Approach - 3E05028
  • Introduction Peripheral Artery to Other Anti-infective with Anti-infective, Open Approach - 3E05029
  • Introduction Peripheral Artery to No Qualifier with Anti-inflammatory, Open Approach - 3E0503Z
  • Introduction Peripheral Artery to No Qualifier with Serum, Toxoid and Vaccine, Open Approach - 3E0504Z
  • Introduction Peripheral Artery to No Qualifier with Nutritional Substance, Open Approach - 3E0506Z
  • Introduction Peripheral Artery to No Qualifier with Electrolytic and Water Balance Substance, Open Approach - 3E0507Z
  • Introduction Peripheral Artery to No Qualifier with Intracirculatory Anesthetic, Open Approach - 3E050FZ
  • Introduction Peripheral Artery to Other Substance with Other Therapeutic Substance, Open Approach - 3E050GC
  • Introduction Peripheral Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Open Approach - 3E050GN
  • Introduction Peripheral Artery to No Qualifier with Radioactive Substance, Open Approach - 3E050HZ
  • Introduction Peripheral Artery to No Qualifier with Other Diagnostic Substance, Open Approach - 3E050KZ
  • Introduction Peripheral Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach - 3E050NZ
  • Introduction Peripheral Artery to No Qualifier with Platelet Inhibitor, Open Approach - 3E050PZ
  • Introduction Peripheral Artery to No Qualifier with Antiarrhythmic, Open Approach - 3E050RZ
  • Introduction Peripheral Artery to No Qualifier with Destructive Agent, Open Approach - 3E050TZ
  • Introduction Peripheral Artery to Insulin with Hormone, Open Approach - 3E050VG
  • Introduction Peripheral Artery to Human B-type Natriuretic Peptide with Hormone, Open Approach - 3E050VH
  • Introduction Peripheral Artery to Other Hormone with Hormone, Open Approach - 3E050VJ
  • Introduction Peripheral Artery to Immunostimulator with Immunotherapeutic, Open Approach - 3E050WK
  • Introduction Peripheral Artery to Immunosuppressive with Immunotherapeutic, Open Approach - 3E050WL
  • Introduction Peripheral Artery to No Qualifier with Vasopressor, Open Approach - 3E050XZ
  • Introduction Peripheral Artery to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E05302
  • Introduction Peripheral Artery to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E05303
  • Introduction Peripheral Artery to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E05305
  • Introduction Peripheral Artery to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0530M
  • Introduction Peripheral Artery to Clofarabine with Antineoplastic, Percutaneous Approach - 3E0530P
  • Introduction Peripheral Artery to Recombinant Human-activated Protein C with Thrombolytic, Percutaneous Approach - 3E05316
  • Introduction Peripheral Artery to Other Thrombolytic with Thrombolytic, Percutaneous Approach - 3E05317
  • Introduction Peripheral Artery to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E05328
  • Introduction Peripheral Artery to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E05329
  • Introduction Peripheral Artery to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0533Z
  • Introduction Peripheral Artery to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach - 3E0534Z
  • Introduction Peripheral Artery to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0536Z
  • Introduction Peripheral Artery to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0537Z
  • Introduction Peripheral Artery to No Qualifier with Intracirculatory Anesthetic, Percutaneous Approach - 3E053FZ
  • Introduction Peripheral Artery to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E053GC
  • Introduction Peripheral Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Percutaneous Approach - 3E053GN
  • Introduction Peripheral Artery to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E053HZ
  • Introduction Peripheral Artery to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E053KZ
  • Introduction Peripheral Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E053NZ
  • Introduction Peripheral Artery to No Qualifier with Platelet Inhibitor, Percutaneous Approach - 3E053PZ
  • Introduction Peripheral Artery to No Qualifier with Antiarrhythmic, Percutaneous Approach - 3E053RZ
  • Introduction Peripheral Artery to No Qualifier with Destructive Agent, Percutaneous Approach - 3E053TZ
  • Introduction Peripheral Artery to Insulin with Hormone, Percutaneous Approach - 3E053VG
  • Introduction Peripheral Artery to Human B-type Natriuretic Peptide with Hormone, Percutaneous Approach - 3E053VH
  • Introduction Peripheral Artery to Other Hormone with Hormone, Percutaneous Approach - 3E053VJ
  • Introduction Peripheral Artery to Immunostimulator with Immunotherapeutic, Percutaneous Approach - 3E053WK
  • Introduction Peripheral Artery to Immunosuppressive with Immunotherapeutic, Percutaneous Approach - 3E053WL
  • Introduction Peripheral Artery to No Qualifier with Vasopressor, Percutaneous Approach - 3E053XZ
  • Introduction Central Artery to High-dose Interleukin-2 with Antineoplastic, Open Approach - 3E06002
  • Introduction Central Artery to Low-dose Interleukin-2 with Antineoplastic, Open Approach - 3E06003
  • Introduction Central Artery to Other Antineoplastic with Antineoplastic, Open Approach - 3E06005
  • Introduction Central Artery to Monoclonal Antibody with Antineoplastic, Open Approach - 3E0600M
  • Introduction Central Artery to Clofarabine with Antineoplastic, Open Approach - 3E0600P
  • Introduction Central Artery to Recombinant Human-activated Protein C with Thrombolytic, Open Approach - 3E06016
  • Introduction Central Artery to Other Thrombolytic with Thrombolytic, Open Approach - 3E06017
  • Introduction Central Artery to Oxazolidinones with Anti-infective, Open Approach - 3E06028
  • Introduction Central Artery to Other Anti-infective with Anti-infective, Open Approach - 3E06029
  • Introduction Central Artery to No Qualifier with Anti-inflammatory, Open Approach - 3E0603Z
  • Introduction Central Artery to No Qualifier with Serum, Toxoid and Vaccine, Open Approach - 3E0604Z
  • Introduction Central Artery to No Qualifier with Nutritional Substance, Open Approach - 3E0606Z
  • Introduction Central Artery to No Qualifier with Electrolytic and Water Balance Substance, Open Approach - 3E0607Z
  • Introduction Central Artery to No Qualifier with Intracirculatory Anesthetic, Open Approach - 3E060FZ
  • Introduction Central Artery to Other Substance with Other Therapeutic Substance, Open Approach - 3E060GC
  • Introduction Central Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Open Approach - 3E060GN
  • Introduction Central Artery to No Qualifier with Radioactive Substance, Open Approach - 3E060HZ
  • Introduction Central Artery to No Qualifier with Other Diagnostic Substance, Open Approach - 3E060KZ
  • Introduction Central Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach - 3E060NZ
  • Introduction Central Artery to No Qualifier with Platelet Inhibitor, Open Approach - 3E060PZ
  • Introduction Central Artery to No Qualifier with Antiarrhythmic, Open Approach - 3E060RZ
  • Introduction Central Artery to No Qualifier with Destructive Agent, Open Approach - 3E060TZ
  • Introduction Central Artery to Insulin with Hormone, Open Approach - 3E060VG
  • Introduction Central Artery to Human B-type Natriuretic Peptide with Hormone, Open Approach - 3E060VH
  • Introduction Central Artery to Other Hormone with Hormone, Open Approach - 3E060VJ
  • Introduction Central Artery to Immunostimulator with Immunotherapeutic, Open Approach - 3E060WK
  • Introduction Central Artery to Immunosuppressive with Immunotherapeutic, Open Approach - 3E060WL
  • Introduction Central Artery to No Qualifier with Vasopressor, Open Approach - 3E060XZ
  • Introduction Central Artery to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E06302
  • Introduction Central Artery to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E06303
  • Introduction Central Artery to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E06305
  • Introduction Central Artery to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0630M
  • Introduction Central Artery to Clofarabine with Antineoplastic, Percutaneous Approach - 3E0630P
  • Introduction Central Artery to Recombinant Human-activated Protein C with Thrombolytic, Percutaneous Approach - 3E06316
  • Introduction Central Artery to Other Thrombolytic with Thrombolytic, Percutaneous Approach - 3E06317
  • Introduction Central Artery to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E06328
  • Introduction Central Artery to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E06329
  • Introduction Central Artery to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0633Z
  • Introduction Central Artery to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach - 3E0634Z
  • Introduction Central Artery to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0636Z
  • Introduction Central Artery to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0637Z
  • Introduction Central Artery to No Qualifier with Intracirculatory Anesthetic, Percutaneous Approach - 3E063FZ
  • Introduction Central Artery to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E063GC
  • Introduction Central Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Percutaneous Approach - 3E063GN
  • Introduction Central Artery to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E063HZ
  • Introduction Central Artery to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E063KZ
  • Introduction Central Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E063NZ
  • Introduction Central Artery to No Qualifier with Platelet Inhibitor, Percutaneous Approach - 3E063PZ